• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.
Advanced
search
ALL

Synonyms(0)

Find out more technical terms

Thesaurus Map Clips

ー



Please login to MyJ-GLOBAL to use J- GLOBAL.
Please register to create your MyJ-GLOBAL account, if you do not have one.
What is MyJ-GLOBAL?
Login Register now
Number of clips is over the max size. (Max number of Clips: 600)
Close
Reset
Go to 「How to search」 page
Advanced search: Search from
　
　Select basic information for advanced search
Free word
～
Chemical structure search
How to Search
NEW R FG i
C N O S F Cl Br I P X
JSME Molecular Editor by Peter Ertl and Bruno Bienfait
drag out MOL or RXN file
Import

MOLfile format is only available (V3000 format is not available)

              
Details
Related links
Search

Co-authoring Researcher

Co-inventing Researcher

Researcher similar to the Researcher

Article similar to the Researcher

Patent similar to the Researcher

Research Project similar to the Researcher

Article(J-GLOBAL estimation)

Patent(J-GLOBAL estimation)

Rchr
J-GLOBAL ID：201801019188964231   Update date: Apr. 13, 2025

WATANABE Masahiro

ワタナベ マサヒロ | WATANABE Masahiro
Clips
Affiliation and department：
Shujitsu University School of PharmacyDepartment of Pharmaceutical Sciences

About Shujitsu University School of PharmacyDepartment of Pharmaceutical Sciences


Research field  (3)： Molecular biology ,  Pharmacology ,  Clinical pharmacy
Research theme for competitive and other funds  (6)：
  • 2021 - 2024 内因性AGEによる組織リモデリング増悪化機構の解明と新規標的治療法の創成
  • 2021 - 2024 炎症抑制性DAMPsの新規同定と炎症性疾患における病態生理学的意義の解明
  • 2018 - 2021 Elucidation of the pathogenic mechanism of chronic inflammation based on AGE-induced cytokine trapping
  • 2018 - 2021 Study of the pathophysiological significance of endogenous AGE as an exacerbating factor for tissue remodeling, and the development of novel targeted therapy
  • 2015 - 2018 Roles of AGEs as exacerbation factor in pathogenesis of tissue remodeling and the development of novel targeted therapy
Show all
Papers (51)：
  • Masahiro Watanabe, Takao Toyomura, Hidenori Wake, Takashi Nishinaka, Omer Faruk Hatipoglu, Hideo Takahashi, Masahiro Nishibori, Shuji Mori. Metolazone and Azosemide, Clinically Utilized Diuretics, Exhibit Inhibitory Activity for Glyoxalase I. Biotechnology and applied biochemistry. 2025. e2760
  • Omer Faruk Hatipoglu, Takashi Nishinaka, Kursat Oguz Yaykasli, Shuji Mori, Masahiro Watanabe, Takao Toyomura, Masahiro Nishibori, Satoshi Hirohata, Hidenori Wake, Hideo Takahashi. Histidine-rich glycoprotein inhibits TNF-α-induced tube formation in human vascular endothelial cells. Frontiers in pharmacology. 2025. 16. 1561628-1561628
  • Masahiro Watanabe, Takao Toyomura, Hidenori Wake, Takashi Nishinaka, Omer Faruk Hatipoglu, Hideo Takahashi, Masahiro Nishibori, Shuji Mori. Cationic ribosomal proteins can inhibit pro-inflammatory action stimulated by LPS+HMGB1 and are hindered by advanced glycation end products. Biotechnology and applied biochemistry. 2023
  • Takashi Nishinaka, Omer Faruk Hatipoglu, Hidenori Wake, Masahiro Watanabe, Takao Toyomura, Shuji Mori, Masahiro Nishibori, Hideo Takahashi. Different modulation of STING/TBK1/IRF3 signaling by advanced glycation end products. Archives of biochemistry and biophysics. 2023. 750. 109808-109808
  • Tatsuya Tai, Takaaki Yamamoto, Kazunori Yamaguchi, Masahiro Watanabe, Hiroaki Tanaka, Yuichi Muraki, Shinji Kosaka. Evaluation of the meropenem dosage and administration schedule in patients with bacteremia initial therapy. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023. 29. 8. 749-753
ｍore...
MISC (76)：
  • 豊村隆男, 渡邊政博, 森秀治, 豊村隆男, 渡邊政博, 森秀治. Novel potential drug target for diabetic complications therapy, Glyoxalase I. 就実大学薬学雑誌. 2024. 11
  • 山口 佳津騎, 田井 達也, 水岡 大策, 渡邊 政博, 阿部 武由, 越野 優希, 田中 裕章, 小坂 信二. バンコマイシンのAUCモニタリングにおける現状と課題 香川県内の病院を対象としたアンケート. TDM研究. 2022. 39. 2. 152-152
  • 豊村 隆男, 渡邊 政博, 和氣 秀徳, 西中 崇, オメル・ハティポール, 高橋 英夫, 西堀 正洋, 森 秀治. グリコールアルデヒド由来AGEsによるマクロファージ増殖亢進. 日本薬学会年会要旨集. 2022. 142年会. 28PO1-18
  • TOYOMURA Takao, WATANABE Masahiro, MORI Shuji. TLR4-independent promotion of the osteoclast differentiation by detoxified LPS. 就実大学薬学雑誌. 2022. 9
  • 田井達也, 山口佳津騎, 新村航, 松原亜季, 渡邊政博, 間嶋由美子, 横田恭子, 田中裕章, 小坂信二, 門脇則光. アミノ酸含有総合電解質輸液処方患者に対する投与速度適正化への取り組みが患者アウトカムに与える影響. 日本医療薬学会年会講演要旨集(Web). 2022. 32
ｍore...
Books (3)：
  • ラクトフェリン2019 ラクトフェリンの基盤的基礎研究の深化と応用開発研究の進化
    アイ・ケイコーポレーション 2019
  • ZERO→ONE スタートアップTDM
    南山堂 2019
  • ラクトフェリン2017 ラクトフェリンの医療分野での現状と今後への期待
    アイ・ケイコーポレーション 2017
Works (1)：
  • EasyTDM
    香川県病院薬剤師会TDM委員会
Education (3)：
  • - 2011 The University of Tokushima Graduate School of Pharmaceutical Sciences
  • - 2006 The University of Tokushima Graduate School of Pharmaceutical Sciences
  • - 2004 The University of Tokushima Faculty of Pharmaceutical Sciences School of Pharmacy
Professional career (1)：
  • 博士(薬学) (徳島大学)
Work history (6)：
  • 2023/04 - 現在 Shujitsu University School of Pharmacy
  • 2019/04 - 2023/03 Shujitsu University School of Pharmacy
  • 2015/04 - 2019/03 Shujitsu University School of Pharmacy
  • 2012/11 - 2015/03 Kagawa University Faculty of Medicine
  • 2009/01 - 2015/03 Kagawa University University Hospital, Faculty of Medicine
Show all
Awards (1)：
  • 2019/11 - 日本薬学会中国四国支部奨励賞
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM